Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to FDA submission.

Compass Pathways (CMPS) added ~20% in the premarket on Tuesday after the U.K.-based biotech announced that its psychedelic therapy COMP360 reached the primary endpoint in a late-stage trial for ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Compass Pathways on ...

The new robotic industry may have some surprise funding sources (“The Robot Revolution Is Real. Tesla, Hyundai, and More Stocks to Play It,” Cover Story, Feb. 6). For example, long-term care insurance ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Apollo at work. Apollo is Apptronik's humanoid robot. The company is looking to scale ...

Boulder, CO and Pasadena, CA — February 11, 2026 — Motiv Space Systems announced a contractual agreement with PickNik Robotics to support software development for NASA’s Fly Foundational Robotics (FFR ...

Santos recorded 18 points (6-9 FG, 3-6 3Pt, 3-5 FT), four rebounds, seven assists, one block and one steal over 36 minutes during Thursday's 101-97 victory over the Suns. Making his fourth start in ...

INDIANAPOLIS — Purdue University and its partners are launching a new center in Indianapolis to advance the use of artificial intelligence and robotics in medicine. The Center for AI and Robotic ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Alan Boyle on Jan 14, 2026 at 8:15 ...

According to most predictions, this year was expected to be the breakout moment for robotics at CES, and in many ways, it was. While physical robots generated the biggest immediate buzz on the ...